Author

F. Ban

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 2 Organism:mouse· 2 Approach:deep learning· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Cherkasov· 3 shared A. Bolotokova· 1 shared A. Dong· 1 shared A. Edwards· 1 shared A. Fuerll· 1 shared A. Gunnarsson· 1 shared A. Hillisch· 1 shared A. Hogner· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

A. Cherkasov

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CACHE Challenge #1: targeting the WDR domain of LRRK2, a Parkinson's Disease associated protein.

S. Ackloo, C. H. Arrowsmith, F. Ban, C. J. Barden, H. Beck, J. Beranek, F. Berenger, A. Bolotokova, G. Bret, M. Breznik, E. Carosati, I. Chau, Y. Chen, A. Cherkasov, D. Della Corte, , Klebe

The paper evaluates computational hit-finding methods for targeting the WDR domain of LRRK2, a Parkinson's disease protein, finding that diverse strategies yielded weakly potent compounds.

bioRxiv · Jul 18, 2024Biochemistry

5'-S-(3-aminophenyl)-5'-thioadenosine, a novel chemoprotective agent for reducing toxic side effects of fluorouracil in treatment of MTAP-deficient cancers

S. Zhang, H. Xue, N. K. Y. Wong, T. Doerksen, F. Ban, S. Anderson, S. Volik, Y.-Y. Lin, Z. Dai, I. Bratanovic, H. Cheng, C. C. Collins, A. Cherkasov, J. Wulff, Y. Wang

This paper identifies m-APTA, an MTA analogue that reduces NBA toxicity without hypothermia, improving safety for MTAP-deficient cancer treatment.

bioRxiv · Apr 17, 2024Cancer Biology

Interleukin-10 and Small Molecule SHIP1 Allosteric Regulators Trigger Anti-Inflammatory Effects Through SHIP1/STAT3 Complexes

T. C. Chamberlain, S. T. Cheung, J. S. J. Yoon, A. Ming-Lum, B. R. Gill, S. Shakibakho, E. Dzananovic, F. Ban, A. Samiea, K. Jawanda, J. Priatel, G. Krystal, C. J. Ong, A. Cherkasov, R. J. Andersen, , A. L.-F. Mui

The paper shows IL10 induces a SHIP1/STAT3 complex in macrophages, and SHIP1 activators mimic IL10's anti-inflammatory effects in colitis.

bioRxiv · May 29, 2020Immunology